Brief: Interpace Diagnostics Announces Coverage Of Molecular Thyroid Testing By Independence Blue Cross
June 20 (Reuters) - Interpace Diagnostics Group Inc
IDXG.O :
* INTERPACE DIAGNOSTICS ANNOUNCES COVERAGE OF MOLECULAR
THYROID
TESTING BY INDEPENDENCE BLUE CROSS
* INTERPACE DIAGNOSTICS GROUP INC - INDEPENDENCE COVERS
NEARLY 2.5
MILLION MEMBERS IN PHILADELPHIA AND SOUTHEASTERN PENNSYLVANIA.
Source text for Eikon: ID:nGNX248f8r
Further company coverage: IDXG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million